Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study. 8922 children (enrolled at 5–17 months) and 6537 infants (enrolled at 6–12 weeks) were 1:1:1-randomi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Vaccin Immunother
Hauptverfasser: Guerra Mendoza, Yolanda, Garric, Elodie, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Pirçon, Jean-Yves, Stegmann, Jens-Ulrich, Vandoolaeghe, Pascale, Otieno, Lucas, Otieno, Walter, Owusu-Agyei, Seth, Sacarlal, Jahit, Masoud, Nahya Salim, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Mtoro, Ali Takadir, Njuguna, Patricia, Oneko, Martina, Otieno, Godfrey Allan, Otieno, Kephas, Gesase, Samwel, Hamel, Mary J, Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lusingu, John, Malabeja, Anangisye, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Schuerman, Lode
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2019
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816384/
https://ncbi.nlm.nih.gov/pubmed/31012786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1586040
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge